The present authors executed an open-label pilot study that administered psilocybin to fifteen treatment method-resistant tobacco/nicotine-dependent people who smoke, from the context of cognitive behavioral therapy for using tobacco cessation [58]. Members were being administered ~0.29 mg/kg oral psilocybin around the participant’s target date t… Read More